Does Pycnogenol Cognition Randomized Trial work?

The current Migaku evidence database contains 2 reusable source documents for Pycnogenol Cognition Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Methodological quality was assessed using the Cochrane Risk of Bias tool, and data were analyzed within a Bayesian framework. [Yang Y (2025); evidence level 1] - Conclusion Pycnogenol showed the highest probability of improving cognitive function and daily living scores in patients with MCI, while Cosmos caudatus supplementation ranked highest for psychological outcomes. [Yang Y (2025); evidence level 1] - Objective This study evaluated the comparative efficacy and safety of eighteen botanical drug interventions in improving cognitive function, daily living activities, and psychological wellbeing in patients with mild cognitive impairment (MCI). [Yang Y (2025); evidence level 1] - Methods Randomized controlled trials were identified from PubMed, Embase, Cochrane Library, and Web of Science up to September 2025. [Yang Y (2025); evidence level 1] - Figure 1 Thus, in the present review we aimed to summarize the preclinical and clinical evidence of selected nutraceuticals, focusing on biotin, flavonoids especially luteolin, folic acid, Huperzine A, Lion’s mane, olive oil polyphenols (oleuropein and hydroxytyrosol [HT]), and palmitoylethanolamide (PEA). [Venetsanaki Vasiliki (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.